scPharmaceuticals Inc. (SCPH)
NASDAQ: SCPH · Real-Time Price · USD
3.390
+0.080 (2.42%)
At close: Dec 20, 2024, 4:00 PM
3.410
+0.020 (0.59%)
After-hours: Dec 20, 2024, 4:10 PM EST
scPharmaceuticals Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for scPharmaceuticals stock have an average target of 15, with a low estimate of 12 and a high estimate of 18. The average target predicts an increase of 342.48% from the current stock price of 3.39.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 14, 2024.
Analyst Ratings
The average analyst rating for SCPH stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +430.97% | Nov 14, 2024 |
Craig-Hallum | Craig-Hallum | Strong Buy Maintains $16 → $12 | Strong Buy | Maintains | $16 → $12 | +253.98% | Nov 14, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +430.97% | Aug 19, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +430.97% | May 15, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +430.97% | Mar 14, 2024 |
Financial Forecast
Revenue This Year
37.26M
from 13.59M
Increased by 174.12%
Revenue Next Year
86.97M
from 37.26M
Increased by 133.41%
EPS This Year
-1.59
from -1.42
EPS Next Year
-0.91
from -1.59
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 39.3M | 101.2M | 213.9M | |||
Avg | 37.3M | 87.0M | 172.9M | |||
Low | 35.2M | 72.5M | 115.6M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 188.9% | 171.7% | 145.9% | |||
Avg | 174.1% | 133.4% | 98.8% | |||
Low | 158.8% | 94.6% | 32.9% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | -1.35 | -0.44 | 1.27 | |||
Avg | -1.59 | -0.91 | 0.48 | |||
Low | -1.98 | -1.27 | 0.01 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | - | - | - | |||
Avg | - | - | - | |||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.